Multiple high blood pressure drugs recalled over long-term cancer risk

  • 📰 CTVNews
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 99%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Several companies are voluntarily recalling their drugs that treat high blood pressure because of a potential impurity that could increase the potential long-term risk of cancer.

The voluntary recall comes after drug maker Teva Canada identified higher levels of N-Nitroso-N-methyl-4-aminobutyric acid , a potential human carcinogen, in one lot of its Losartan-containing drugs.

Health Canada says the amount of NMBA, while not immediately dangerous to patients, is above the levels considered reasonably safe if ingested over a life time. As a result, drug makers Apotex Inc., Pharmascience Inc., and Pro Doc Limitée have also recalled several lots of their Losartan-containing products as a precautionary measure.Lorsartan is a drug used to help prevent heart attacks and stroke in patients with high blood pressure, as well as for patients who have experienced heart failure.

Health Canada recommends patients don’t stop taking their medication unless advised to by their healthcare provider.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Just makes my blood boil.

Whoa. Thx. I am on some meds. I will check them!

I find it hard to believe such drugs cannot be produced in Canada. Why outsource drug manufacturing?

No charges?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in BUSİNESS

Business Business Latest News, Business Business Headlines